PubRank

S Eva Singletary

Author PubWeight™ 128.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy. J Clin Oncol 2007 7.00
2 Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 2006 3.53
3 Mammography before diagnosis among women age 80 years and older with breast cancer. J Clin Oncol 2008 3.49
4 Oncologic safety of skin-sparing mastectomy. Ann Surg Oncol 2003 3.32
5 Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 2006 2.84
6 Breast cancer on the world wide web: cross sectional survey of quality of information and popularity of websites. BMJ 2002 2.53
7 Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 2002 2.51
8 Career satisfaction, practice patterns and burnout among surgical oncologists: report on the quality of life of members of the Society of Surgical Oncology. Ann Surg Oncol 2007 2.50
9 Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 2003 2.29
10 Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann Surg Oncol 2006 2.23
11 Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 2002 2.21
12 Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 2003 2.19
13 Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. J Clin Oncol 2005 2.07
14 Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 2002 2.07
15 Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience. J Clin Oncol 2004 2.00
16 Should surgical recertification reflect subspecialization? Am J Surg 2008 1.93
17 Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol 2007 1.92
18 Surgical decision making and factors determining a diagnosis of breast carcinoma in women presenting with nipple discharge. J Am Coll Surg 2003 1.81
19 Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years. Ann Surg 2002 1.79
20 Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer. Ann Surg Oncol 2003 1.74
21 Timing of surgical intervention for the intact primary in stage IV breast cancer patients. Ann Surg Oncol 2008 1.71
22 Treatment and outcome of patients with intracystic papillary carcinoma of the breast. Am J Surg 2002 1.70
23 Trends for inflammatory breast cancer: is survival improving? Oncologist 2007 1.70
24 Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumor size in patients treated with neoadjuvant chemotherapy. Ann Surg 2006 1.70
25 Anaphylactoid reactions to isosulfan blue dye during breast cancer lymphatic mapping in patients given preoperative prophylaxis. J Clin Oncol 2004 1.61
26 Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J Am Coll Surg 2005 1.61
27 Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival. Cancer 2007 1.54
28 Effective local control and long-term survival in patients with T4 locally advanced breast cancer treated with breast conservation therapy. Ann Surg Oncol 2004 1.52
29 Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. Int J Radiat Oncol Biol Phys 2002 1.51
30 T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 2004 1.51
31 Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry. Cancer 2005 1.50
32 Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 2002 1.45
33 Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003 1.45
34 Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 2004 1.45
35 Breast cancer in reduction mammaplasty specimens: case reports and guidelines. Breast J 2003 1.41
36 Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study. Cancer 2010 1.39
37 A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility. Ann Surg Oncol 2002 1.33
38 Intraoperative margin assessment reduces reexcision rates in patients with ductal carcinoma in situ treated with breast-conserving surgery. Am J Surg 2003 1.33
39 Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin 2002 1.32
40 Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. Radiology 2004 1.29
41 Multidisciplinary management of breast cancer concurrent with pregnancy. J Am Coll Surg 2002 1.25
42 Predictors of local-regional recurrence after neoadjuvant chemotherapy and mastectomy without radiation. J Clin Oncol 2002 1.20
43 The effect of ethnicity on immediate reconstruction rates after mastectomy for breast cancer. Cancer 2004 1.18
44 Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Cancer 2004 1.18
45 Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 2004 1.17
46 Contralateral prophylactic mastectomy. Predictors of significant histologic findings. Cancer 2004 1.16
47 Locoregional treatment outcomes after multimodality management of inflammatory breast cancer. Int J Radiat Oncol Biol Phys 2008 1.15
48 Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 2005 1.14
49 The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer. Clin Cancer Res 2005 1.12
50 Breast cancer recurrence after immediate reconstruction: patterns and significance. Plast Reconstr Surg 2003 1.09
51 Chest wall recurrence after mastectomy does not always portend a dismal outcome. Ann Surg Oncol 2003 1.08
52 Improving local control with breast-conserving therapy: a 27-year single-institution experience. Cancer 2005 1.08
53 Breast conservation after neoadjuvant chemotherapy. Cancer 2005 1.04
54 Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer 2004 1.03
55 Predictors of locoregional recurrence among patients with early-stage breast cancer treated with breast-conserving therapy. Ann Surg Oncol 2002 1.02
56 The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial. J Clin Oncol 2004 1.02
57 Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial. Clin Cancer Res 2002 1.01
58 Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years. Carcinogenesis 2006 1.00
59 Nipple aspirate fluid cytology in breast carcinoma. Cancer 2003 0.97
60 Predictors of systemic recurrence and disease-specific survival after ipsilateral breast tumor recurrence. Cancer 2005 0.96
61 Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy. Ann Surg Oncol 2006 0.95
62 Paget's disease of the breast: there is a role for breast-conserving therapy. Ann Surg Oncol 2005 0.95
63 High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. Clin Cancer Res 2003 0.93
64 Breast cancer vaccines: promise for the future or pipe dream? Cancer 2007 0.93
65 Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer. Int J Radiat Oncol Biol Phys 2002 0.92
66 Epidermal growth factor receptor expression correlates with poor survival in patients who have breast carcinoma treated with doxorubicin-based neoadjuvant chemotherapy. Cancer 2005 0.92
67 Treatment and outcome of patients with chest wall recurrence after mastectomy and breast reconstruction. Am J Surg 2004 0.89
68 Current comprehensive assessment and management of women at increased risk for breast cancer. Am J Surg 2004 0.89
69 Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer 2005 0.89
70 Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg 2006 0.87
71 Implications of axillary sentinel lymph node biopsy in immediate autologous breast reconstruction. Plast Reconstr Surg 2002 0.87
72 Expressive writing as a presurgical stress management intervention for breast cancer patients. J Soc Integr Oncol 2008 0.87
73 The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy. Cancer 2006 0.87
74 Changes in female support network systems and adaptation after breast cancer diagnosis: differences between older and younger patients. Gerontologist 2009 0.85
75 Overview of adjuvant systemic therapy in early stage breast cancer. Surg Clin North Am 2007 0.84
76 A review of technical aspects of sentinel lymph node identification for breast cancer. J Am Coll Surg 2002 0.83
77 Lower and central tumor location correlates with lymphoscintigraphy drainage to the internal mammary lymph nodes in breast carcinoma. Cancer 2005 0.83
78 Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer 2006 0.83
79 Genetic variants in the H2AFX promoter region are associated with risk of sporadic breast cancer in non-Hispanic white women aged <or=55 years. Breast Cancer Res Treat 2007 0.83
80 Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cancer 2004 0.83
81 Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer. J Am Coll Surg 2006 0.82
82 Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study. Cancer 2004 0.82
83 Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study. Cancer 2002 0.81
84 Dietary intake of selected fatty acids, cholesterol and carotenoids and estrogen receptor status in premenopausal breast cancer patients. Breast Cancer Res Treat 2002 0.81
85 Breast-conservation therapy in early-stage breast cancer patients with a positive family history. Ann Surg Oncol 2002 0.81
86 Disease-free and overall survival after pathologic complete disease remission of cytologically proven inflammatory breast carcinoma axillary lymph node metastases after primary systemic chemotherapy. Cancer 2006 0.80
87 Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy. Breast Cancer Res Treat 2003 0.80
88 Determinants of mastectomy in breast conservation therapy candidates. Am J Surg 2005 0.79
89 Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast. J Interferon Cytokine Res 2002 0.78
90 Management of breast carcinoma identified intraoperatively during reduction mammaplasty. Ann Plast Surg 2003 0.77
91 Fifteen-year results of a randomized prospective trial of hyperfractionated chest wall irradiation versus once-daily chest wall irradiation after chemotherapy and mastectomy for patients with locally advanced noninflammatory breast cancer. Int J Radiat Oncol Biol Phys 2006 0.77
92 Minimally invasive ablation techniques in breast cancer treatment. Ann Surg Oncol 2002 0.76
93 Candidates for minimally invasive therapy of breast cancer: redefining the standards. Ann Surg Oncol 2003 0.75
94 A step-by-step guide to breast self-examination. Oncology (Williston Park) 2005 0.75
95 The need for breast cancer screening in women undergoing elective breast surgery: an assessment of risk and risk factors for breast cancer in young women. Aesthet Surg J 2010 0.75